Probity Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$288K Sell
426
-27
-6% -$16K 0.04% 202
2026
Q2
$227K Sell
453
-46
-9% -$22.1K 0.03% 222
2026
Q1
$245K Sell
499
-9
-2% -$4.88K 0.04% 217
2025
Q4
$294K Sell
508
-74
-13% -$41.8K 0.05% 203
2025
Q3
$282K Sell
582
-13
-2% -$6.05K 0.05% 207
2025
Q2
$241K Buy
595
+184
+45% +$76.9K 0.04% 211
2025
Q1
$205K Buy
+411
New +$223K 0.04% 223

Other funds holding TMO

Probity Advisors's TMO Position: Q3 2026 in Review

Probity Advisors reduced its Thermo Fisher Scientific (TMO) stake by 6% in Q3 2026, selling an estimated $16K and leaving 426 shares worth $288K. The position accounts for 0.04% of the portfolio, ranked #202.

Probity Advisors first reported a position in TMO in Q1 2025 and has held it in 7 quarters since. The position peaked at $294K in Q4 2025. 2,806 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Probity Advisors held 426 shares of Thermo Fisher Scientific worth $288K as of Q3 2026.
  • Probity Advisors sold 27 Thermo Fisher Scientific shares in Q3 2026, an estimated $16K.
  • Thermo Fisher Scientific made up 0.04% of Probity Advisors's portfolio in Q3 2026, its #202 holding.
  • Probity Advisors first reported a position in Thermo Fisher Scientific in Q1 2025 and has held it in 7 quarters since.
  • Probity Advisors's Thermo Fisher Scientific position peaked at $294K in Q4 2025.
  • 2,806 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Probity Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.